Real Examples Of False Claims

U.S. v. Bank of America

A former bank executive at Countrywide Financial (which is now owned by Bank of America Corporation) was awarded $57 million for exposing the presence of fraud in the company's mortgage practices. The case was filed under the False Claims Act.

U.S. v. Cooper Health Systems

A $12.6 million settlement was reached with the U.S. Attorney's office for this New Jersey hospital system's illegal payments of millions of dollars in illegal kickbacks to physicians to induce them to refer patients to the hospital for expensive in-patient and out-patient cardiac services.

U.S. v. RehabCare Group

A $30 million settlement was reached with the U.S. Attorney's office for this division of Kindred Healthcare Inc. for an illegal kickback scheme concerning nursing home referrals.

U.S. v. Maxim Staffing Solutions

A $150 million settlement was reached with the U.S. Attorney's office for this medical staffing company's fraudulent billing of Medicaid for services that were not provided.

U.S. v. LHC Group

A $65 million settlement was reached with the U.S. Attorney's office for home health care provider billing fraud.

U.S. v. Odyssey Healthcare

A $25 million settlement was reached with the U.S. Attorney's office for billing for hospice care not legally covered by Medicare.

U.S. v. Ranbaxy Inc.

A $350 million civil settlement was reached with the U.S. Attorney's office and this pharmaceutical manufacturer because of false statements made to the Food and Drug Administration (FDA) relating to the stability of the drugs, which were purchased by federally funded health care programs.

U.S. v. Johnson & Johnson

A $2.2 billion civil settlement was reached with the U.S. Attorney's office because of kickbacks and violations of the FDA's marketing regulations for pharmaceuticals.

U.S. v. Johnson & Johnson

A $158 million civil settlement was reached with the U.S. Attorney's office for the off-label marketing of the prescription drug Risperdal.

U.S. v. McLeod Cancer & Blood Center

A $4.25 million settlement was reached with the U.S. Attorney's office because drugs that were not approved for use in the United States were relabeled as approved drugs and then billed to federal health care programs.

U.S. v. Maersk Shipping Lines

A $31 million civil settlement was reached with the U.S. Attorney's office for submitting inflated cargo invoices for goods shipped to U.S. troops in Afghanistan and Iraq.

To arrange a consultation with one of our experienced attorneys, call 856-208-5748 or send us an email.